Editas Medicine (EDIT) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to -$1.6 billion.
- Editas Medicine's Retained Earnings fell 1404.27% to -$1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 billion, marking a year-over-year decrease of 1404.27%. This contributed to the annual value of -$1.5 billion for FY2024, which is 1925.47% down from last year.
- Editas Medicine's Retained Earnings amounted to -$1.6 billion in Q3 2025, which was down 1404.27% from -$1.6 billion recorded in Q2 2025.
- In the past 5 years, Editas Medicine's Retained Earnings registered a high of -$721.9 million during Q1 2021, and its lowest value of -$1.6 billion during Q3 2025.
- In the last 5 years, Editas Medicine's Retained Earnings had a median value of -$1.2 billion in 2023 and averaged -$1.2 billion.
- In the last 5 years, Editas Medicine's Retained Earnings crashed by 3544.05% in 2021 and then plummeted by 1404.27% in 2025.
- Editas Medicine's Retained Earnings (Quarter) stood at -$857.7 million in 2021, then dropped by 25.7% to -$1.1 billion in 2022, then fell by 14.21% to -$1.2 billion in 2023, then dropped by 19.25% to -$1.5 billion in 2024, then decreased by 10.52% to -$1.6 billion in 2025.
- Its Retained Earnings stands at -$1.6 billion for Q3 2025, versus -$1.6 billion for Q2 2025 and -$1.5 billion for Q1 2025.